EODData

MEMBERSHIP REGISTER LOG IN

FRA, 473A: Adaptimmune Therapeutics plc

20 Oct 2025
LAST:

0.1620

CHANGE:
 0.01		OPEN:
0.1850		HIGH:
0.1850		ASK:
0.0000		VOLUME:
24.5K
CHG(%):
5.81		PREV:
0.1720		LOW:
0.1620		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Oct 250.18500.18500.16200.162024.5K
16 Oct 250.17200.17200.17200.17203.0K
15 Oct 250.13100.13100.13100.13103.0K
14 Oct 250.14900.15900.14900.15903.0K
13 Oct 250.15500.15500.15500.155025.0K
10 Oct 250.17400.19400.17400.194025.0K
09 Oct 250.22000.25000.15200.250090.0K
08 Oct 250.11500.19000.11500.180027.5K
07 Oct 250.10400.10400.10400.104012.0K
06 Oct 250.12800.12800.12200.122025.0K

COMPANY PROFILE

Name:Adaptimmune Therapeutics plc
About:Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the treatment of head and neck cancer. The company also focuses on the development of T-cell therapies directed to PRAME (ADP-600) and CD70 (ADP-520). It has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos' decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; collaboration and license agreement with Noile-Immune Biotech, Inc. and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:60 Jubilee Avenue, Abingdon, United Kingdom, OX14 4RX
Website:https://www.adaptimmune.com
ISIN:US00653A1079
LEI:549300UUNWK8TRT5EW12

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.54 
Forward P/E:-0.16 
PEG Ratio:0.00 
Price to Sales:0.66 
Price to Book:-0.60 
Profit Margin:-2.61 
Operating Margin:-2.21 
Return on Assets:-0.41 
Return on Equity:-13.41 
Revenue:56.38M 
Shares:265.05M 
Market Cap:42.94M 

TECHNICAL INDICATORS

MA5:0.164.0%
MA10:0.160.6%
MA20:0.1412.5%
MA50:0.0985.8%
MA100:0.1511.6%
MA200:0.2659.8%
STO9:39.73
STO14:43.95
RSI14:53.77
WPR14:-56.05
MTM14:0.03
ROC14:0.24 
ATR:0.04 
Week High:0.1914.2%
Week Low:0.1323.7%
Month High:0.2554.3%
Month Low:0.0959.8%
Year High:0.79390.1%
Year Low:0.03548.0%
Volatility:340.04